➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Mallinckrodt
Express Scripts
Boehringer Ingelheim
Colorcon

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Details for Patent: 9,180,200

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,180,200 protect, and when does it expire?

Patent 9,180,200 protects XEPI and is included in one NDA.

This patent has thirty-seven patent family members in twenty-three countries.

Summary for Patent: 9,180,200
Title:Pharmaceutical topical compositions
Abstract: The invention provides pharmaceutical stable semisolid topical compositions comprising between 0.2 to 5% of a des-fluoroquinolone compound, and a suitable carrier to manufacture an ointment or a cream.
Inventor(s): Tarrago; Cristina (Esplugues del Llobregat, ES), Santos; Benjamin (Barcelona, ES), Raga; Manuel (Barcelona, ES), Guglietta; Antonio (Molins de Rei, ES)
Assignee: FERRER INTERNATIONAL, S.A. (Barcelona, ES)
Application Number:13/124,403
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound;

Drugs Protected by US Patent 9,180,200

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ferrer Internacional XEPI ozenoxacin CREAM;TOPICAL 208945-001 Dec 11, 2017 RX Yes Yes   Start Trial   Start Trial Y TREATMENT OF IMPETIGO DUE TO STAPHYLOCOCCUS AUREUS OR STREPTOCOCCUS PYOGENES   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,180,200

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
08166933Oct 17, 2008
PCT Information
PCT FiledOctober 16, 2009PCT Application Number:PCT/EP2009/063625
PCT Publication Date:April 22, 2010PCT Publication Number: WO2010/043717

International Family Members for US Patent 9,180,200

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 073901   Start Trial
Australia 2009305360   Start Trial
Brazil PI0920355   Start Trial
Canada 2738384   Start Trial
Canada 2822167   Start Trial
Chile 2011000848   Start Trial
Chile 2015002899   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Johnson and Johnson
Baxter
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.